Skip to main content
. 2019 Apr 21;65(6):592–602. doi: 10.1093/tropej/fmz019

Table 2.

Clinical features up to 12 months of children of mothers who developed rash during pregnancy

Clinical features Group 1 RT-qPCR+ Group 2 RT-qPCR- Group 3 No RT-qPCR Total
n = 43 n = 26 n = 39 n = 108
no. (%) no. (%) no. (%) no. (%)
Small for gestational age 5 (12) 5 (19) 4 (10) 14 (13)
CZS 13 (30) 0 13 (33) 26 (24)
Time of diagnosis of CZS (n= 13) (n= 0) (n= 13) (n= 26)
 At birth 5 (38) 0 7 (54) 12 (46)
 Up to 10 months of life 8 (62) 0 6 (46) 14 (54)
Microcephaly 6 (14) 0 12 (31) 18 (16)
Time of diagnosis of microcephaly
 At birtha 8 (19) 1 (4) 7 (18) 16 (15)
 After birth 1 (3) 0 5 (13) 6 (6)
Neurological findings  b (n= 43) (n= 25) (n= 38) (n= 106)
 Normal 27 (62) 24 (96) 22(58) 73 (69)
 Mild 1 (3) 1 (4) 0 2 (2)
 Moderate 10 (23) 0 6 (16) 16 (15)
 Severe 5 (12) 0 10 (26) 15 (14)
Ophthalmologic examination (n= 38) (n= 25) (n= 34) (n=97)
 Optic nerve abnormalitiesc 5 (13) 0 4 (12) 9 (9)
 Choriorretinal abnormalitiesc 5 (13) 0 6 (18) 11 (11)
Orthopedic examination
 Arthrogryposisd 1 (3) 0 7 (18) 8 (7)
 Clubfoot 4 (9) 1 (4) 7 (18) 12 (11)
 Congenital hip dysplasia 1 (3) 0 1(3) 2 (2)
Dysphagiae 13 (30) 0 14 (37) 27 (25)
Low weight for agef 6 (14) 0 4 (10) 10 (9)
Time of maternal rash / CZS children (n=13) (n= 0) (n= 13)
 before pregnancyg 1 (8) 0 0 1 (4)
 1st trimester 7 (54) 0 11 (84) 18 (69)
 2nd trimester 4 (30) 0 1 (8) 5 (19)
 3rd trimester 1 (8) 0 1 (8) 2 (8)
a

HC of three children in Group 1 and one in Group 2 normalized during the follow-up period.

b

Eight CZS children in Group 1 and three in Group 3 had moderate neurological findings. All severe neurological findings were observed in CZS children.

c

Observed in 12 CZS children.

d

Only seen in CZS children.

e

Observed in 11 CZS children of Group 1 and 13 of Group 3.

f

Seven CZS children had low weight for age (<−2 z score; WHO, 2016).

g

Up to 3 months before pregnancy.

CZS, congenital Zika syndrome; RT-qPCR, reverse transcription polymerase chain reaction.